Form 4: Inovio Pharmaceuticals Director Wendy Yarno Reports Stock Transactions
SEC Form 4 Filing
Director Wendy Yarno reports the vesting and acquisition of 2,166 shares of Inovio Pharmaceuticals common stock through restricted stock units.
Summary
- On May 15, 2024, Wendy Yarno, a director of Inovio Pharmaceuticals, acquired 2,166 shares of common stock.
- The acquisition resulted from the vesting of restricted stock units.
- Following the transaction, Yarno directly owns 8,345 shares of Inovio Pharmaceuticals.
- The restricted stock units vested 100% on May 15, 2024.
- The reported figures give effect to a 1-for-12 reverse stock split that Inovio Pharmaceuticals implemented on January 24, 2024.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by a company director, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which can be informative for investors.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| January 24, 2024 | 1-for-12 reverse stock split effected by Inovio Pharmaceuticals |
| May 15, 2024 | Date of transaction and vesting of restricted stock units |
| May 16, 2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.